{
    "eid": "2-s2.0-84954310160",
    "title": "Correlation of Fc\u03b3RIIIa polymorphisms to the response of rituximab in Thai patients with diffuse large B-cell lymphoma",
    "cover-date": "2015-12-01",
    "subject-areas": [
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [
        "Anti CD20",
        "Diffuse large B-cell lymphoma",
        "Fc\u03b3RIIIa polymorphism",
        "Rituximab"
    ],
    "authors": [
        "Naruemol Angsirisak"
    ],
    "citedby-count": 2,
    "ref-count": 22,
    "ref-list": [
        "Non-Hodgkin's lymphomas in Thailand: A retrospective pathologic and clinical analysis of 1391 cases",
        "The 2008 WHO classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications",
        "Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes.",
        "Rituximab: A new therapeutic monoclonal antibody for non-Hodgkin's lymphoma",
        "CD20-mediated apoptosis: Signalling through lipid rafts",
        "Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma",
        "In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas",
        "Rituximab-dependent cytotoxicity by natural killer cells: Influence of FCGR3A polymorphism on the concentration-effect relationship",
        "Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets",
        "Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fc\u03b3rIIIa gene",
        "Rituximab (monoclonal anti-CD20 antibody): Mechanisms of action and resistance",
        "FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma",
        "FC\u03b3RIIIA and FC\u03b3RIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma",
        "Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype",
        "Ethnic variation of Fc\u03b3 receptor polymorphism in Sami and Norwegian populations",
        "Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma",
        "Correlation of Fc\u03b3RIIIa polymorphisms and responses to rituximab in Thai population",
        "Fc\u03b3RIIIa and Fc\u03b3RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia",
        "Fc\u03b3RIIIA and Fc\u03b3RIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab",
        "Fc\u03b3 receptor IIIA polymorphisms and efficacy of rituximab therapy on Chinese diffuse large B-cell lymphoma",
        "Revised response criteria for malignant lymphoma",
        "Efficacy of hepatitis B immunoglobulin in relation to the gene polymorphisms of human leukocyte Fc\u03b3 receptor III (CD16) in Chinese liver transplant patients"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}